Sichuan University

This study tests whether adding radiotherapy to standard immunotherapy and chemotherapy can help people with advanced small cell lung cancer that has spread to the liver. About 30 adults aged 18-75 whose cancer worsened after prior treatments will receive the combination. The goa…

This early-stage trial tests a new approach: injecting a virus that carries a human gene (endostatin) directly into tumors, along with an immunotherapy drug. The goal is to see if this combination is safe and can shrink tumors in people with advanced head and neck cancer or esoph…

This early-phase study tests a new mRNA drug (WGb-0301) for people with B-cell blood cancers that have come back or not responded to standard treatments. The drug uses lipid nanoparticles to deliver mRNA that targets CD19 on cancer cells. The main goals are to find a safe dose an…

This study tests whether adding the drug ivonescimab to standard chemotherapy (SOX) can better shrink or eliminate tumors in people with locally advanced stomach or gastroesophageal junction cancer. About 154 participants will receive either the combination or chemotherapy alone …

This early-stage study tests a new drug called WGb-0302 for people with blood cancers like multiple myeloma that have come back or stopped responding to other treatments. The drug uses mRNA technology (similar to some COVID-19 vaccines) to help the body target cancer cells. About…

This study tests a combination of two drugs, sacituzumab tirumotecan and anlotinib, in people with extensive-stage small cell lung cancer whose cancer has already been treated. The goal is to see if the combination can shrink tumors. About 33 adults aged 18 to 75 with good perfor…

This study tests whether having patients regularly report their symptoms after esophageal cancer surgery leads to better recovery compared to standard care. About 240 adults aged 18–75 who are scheduled for curative surgery will participate. The goal is to see if this approach re…